| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/17/2008 | CN101264157A Traditional Chinese medicine for treating high blood pressure |
| 09/17/2008 | CN101264155A Medicine for treatment of piles and preparation method thereof |
| 09/17/2008 | CN101264150A Chinese medicinal composition containing radix astragali and preparation thereof |
| 09/17/2008 | CN101264146A Externally-applied Chinese herbal medicine for treating muscle and joint disease and preparation thereof |
| 09/17/2008 | CN101264138A Method for processing calculus bovis bacteriostatic lotion |
| 09/17/2008 | CN101264131A Chinese medicine extracting liquid eye plaster and preparation thereof |
| 09/17/2008 | CN101264130A Film coating agent for treating skin ulcer |
| 09/17/2008 | CN101264107A Bacillus licheniformis medicinal composition and preparations thereof |
| 09/17/2008 | CN101264106A Preparation of lamb stomach extract and its preparation |
| 09/17/2008 | CN101264105A Lamb stomach extract vitamin B12 preparations composing prescription |
| 09/17/2008 | CN101264104A Calf serum de-protein injection and producing method thereof |
| 09/17/2008 | CN101264100A New purpose of mirabilite for treating hyperplasia of mammary glands |
| 09/17/2008 | CN101263830A Multi-effect pesticidal preparations and uses thereof |
| 09/17/2008 | CN101263812A Sterilization disinfectant and preparation |
| 09/17/2008 | CN100419073C Live vaccine for mycoplasma pneumonia of swine and production method thereof |
| 09/17/2008 | CN100419060C Vigorous wine and preparation method thereof |
| 09/17/2008 | CN100419059C Female body building long life liquor |
| 09/17/2008 | CN100418572C Oral Chinese medicine preparation for treating liver and gall bladder diseases |
| 09/17/2008 | CN100418568C Composition of Chinese traditional medicine for dispelling wind-evil, activating collateral flow, strengthening the muscles and bones, preparation method and usage |
| 09/17/2008 | CN100418566C Health-caring essence and preparation method thereof |
| 09/17/2008 | CN100418563C Quality control method of Chinese medicinal preparation |
| 09/17/2008 | CN100418562C Medicinal composition, its preparing method and quality controlling means |
| 09/17/2008 | CN100418561C Chinese medicine composition and its prepn process and quality control method |
| 09/17/2008 | CN100418557C Fracture treating Chinese medicine |
| 09/17/2008 | CN100418551C Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method |
| 09/17/2008 | CN100418546C Skin penetration and adsorption medicine for treating proliferation of mammary gland |
| 09/17/2008 | CN100418542C Hemorrhoids-treating Chinese traditional medicine |
| 09/16/2008 | US7425549 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 09/16/2008 | US7425448 Cells for use as models in the treatment of heart defects |
| 09/16/2008 | US7425343 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/12/2008 | WO2008109717A1 Compositions and methods for treating cancer |
| 09/12/2008 | WO2008109407A2 Extracellular matrix-derived gels and related methods |
| 09/12/2008 | WO2008109398A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | WO2008109063A2 Procurement, isolation and cryopreservation of endometrial/menstrual cells |
| 09/12/2008 | WO2008108412A1 Serum preparation method and serum preparation apparatus |
| 09/12/2008 | WO2008108395A1 Process for producing osteocalcin-containing extract |
| 09/12/2008 | WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell |
| 09/12/2008 | WO2008108298A1 Agent for reducing visceral fat |
| 09/12/2008 | WO2008108262A1 Immunomodulating agent |
| 09/12/2008 | WO2008107746A2 Tablet comprising microorganisms and a combination of excipients and the manufacture process thereof |
| 09/12/2008 | WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | WO2008106827A1 Cosmetic and sanitarian products of cordyceps |
| 09/12/2008 | WO2008106821A1 A chinese medicine composition and the extract of worms thereof and their preparation |
| 09/12/2008 | WO2008085229A3 Cell-based therapies for treating liver disease |
| 09/12/2008 | WO2008081116A3 Cellular preparations for use as a revascularisation stimulating agent |
| 09/12/2008 | WO2008051568A9 Methods and compositions for treatment of bone defects with placental cell populations |
| 09/12/2008 | WO2008019887A3 Probiotic microorganisms for the reduction of manure odor |
| 09/12/2008 | WO2007073176A3 Composition comprising a polyunsaturated fatty acid for improving membrane composition |
| 09/12/2008 | CA2848494A1 Use of lactic acid bacteria for improving food lysine absorption of pet animals |
| 09/12/2008 | CA2679843A1 Bacterial extract for respiratory disorders and process for its preparation |
| 09/12/2008 | CA2679834A1 Procurement, isolation and cryopreservation of endometrial/menstrual cells |
| 09/12/2008 | CA2679765A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2677030A1 Agent for reducing visceral fat |
| 09/11/2008 | US20080221225 Genes associated with restenosis |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080220508 Bacteriophages that infect bacillus bacteria (anthrax) |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | US20080220085 Culture of adipose stem cells; nervous system disorders |
| 09/11/2008 | US20080220084 Combination therapy for alleviating pain-related conditions |
| 09/11/2008 | US20080220083 Pharmaceutical Agent Comprising Blood Components <10 Kda And Their Use For Prophylaxis And Treatment Of Defects Of The Immune System |
| 09/11/2008 | US20080220082 Compositions and methods for treating or preventing hair loss and processes for making the same |
| 09/11/2008 | US20080220044 Cancellous construct with support ring for repair of osteochondral defects |
| 09/11/2008 | US20080220042 Biomolecule-linked biomimetic scaffolds |
| 09/11/2008 | US20080220025 grafting a mixture of alloactivated lymphocytes in a compatible drug excipient, in or around a tumor site, to elicite an antitumor immunology response; cellular immunology and cancer therapy |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
| 09/11/2008 | US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases |
| 09/11/2008 | US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer |
| 09/11/2008 | US20080219961 Method for Stabilising Pharmaceutical Administration Forms Comprising Microorganisms |
| 09/11/2008 | US20080219959 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof |
| 09/11/2008 | US20080219958 Treating neuroblastoma in mammals via exposure to tumor antigen pulsed antigen-presenting cells; tissue targeted therapy; immunotherapy |
| 09/11/2008 | US20080219956 Hla homozygous cells and methods of use thereof |
| 09/11/2008 | US20080219955 Propagating nervous system tissues for use in treatment of stroke, traumatic brain injury, traumatic spinal cord injury, parkinson's, alzheimer's, huntington's, multiple sclerosis or depressive disorders; regenerative medicine; tissue engineering and repair |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219947 Single chain trimers and uses therefor |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967196A1 Harmful bacterium control agent containing bacillus thuringiensis |
| 09/10/2008 | EP1965880A1 A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 09/10/2008 | EP1965840A1 Absorbent article |
| 09/10/2008 | EP1965839A1 Absorbent article |
| 09/10/2008 | EP1965816A2 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| 09/10/2008 | EP1965815A1 Wound healing composition comprising substances obtained from diptera larvae |
| 09/10/2008 | EP1965813A2 Methods of treating fibrosing diseases by induction of immune tolerance |
| 09/10/2008 | EP1965812A2 Acellularized biomaterial from embryonic stem cells |
| 09/10/2008 | EP1965809A2 Novel compositions to improve gut health and animal performance and methods of making the same |
| 09/10/2008 | EP1965804A2 Lyophilized compositions of a triazolopyrimidine compound |